33,478 XNAS Volume
XNAS 28 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.51 per share. | 10 Jan 2025 | 2,500 | 5,552,502 | - | 12.5 | 31,275 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.31 per share. | 06 Jan 2025 | 1,100 | 5,548,202 | - | 13.3 | 14,641 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.75 per share. | 06 Jan 2025 | 1,800 | 5,550,002 | - | 13.8 | 24,750 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.95 per share. | 03 Jan 2025 | 3,400 | 5,547,102 | - | 13.0 | 44,030 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.97 per share. | 02 Jan 2025 | 2,000 | 5,543,702 | - | 12.0 | 23,940 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.36 per share. | 31 Dec 2024 | 2,400 | 5,541,702 | - | 11.4 | 27,264 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.12 per share. | 30 Dec 2024 | 3,200 | 5,539,302 | - | 11.1 | 35,584 | Common Stock |
| Kenneth Hallock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 41,349 | 82,698 | - | - | Stock Options | |
| McWilliams B. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 61,984 | 123,968 | - | - | Stock Options | |
| Eric Rothe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 41,349 | 82,698 | - | - | Stock Options | |
| Frank Daugherty Joseph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 104,890 | 209,780 | - | - | Stock Options | |
| S. Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 25,008 | 2,247,462 | - | - | Stock Options | |
| S. Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 1,148,723 | 2,222,454 | - | - | Stock Options | |
| Jaye Thompson | VP Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 149,818 | 299,636 | - | - | Stock Options | |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 12.91 per share. | 21 Nov 2024 | 1,000 | 264,148 | - | 12.9 | 12,910 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.63 per share. | 26 Sep 2024 | 1,500 | 5,536,102 | - | 14.6 | 21,945 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 13.85 per share. | 12 Aug 2024 | 800 | 263,148 | - | 13.9 | 11,080 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.81 per share. | 06 Aug 2024 | 2,000 | 5,534,602 | - | 13.8 | 27,620 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.18 per share. | 05 Aug 2024 | 5,500 | 5,532,602 | - | 13.2 | 72,490 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 15.15 per share. | 02 Aug 2024 | 1,000 | 262,348 | - | 15.2 | 15,150 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.89 per share. | 23 Jul 2024 | 1,500 | 5,527,102 | - | 15.9 | 23,835 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 18 Jul 2024 | 1,000 | 261,348 | - | 16 | 16,000 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.30 per share. | 13 Jun 2024 | 174,825 | 5,525,602 | - | 14.3 | 2,499,998 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.08 per share. | 01 Apr 2024 | 3,000 | 5,350,777 | - | 19.1 | 57,240 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.98 per share. | 22 Mar 2024 | 2,500 | 5,347,777 | - | 20.0 | 49,950 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.68 per share. | 20 Mar 2024 | 1,500 | 5,345,277 | - | 17.7 | 26,520 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.49 per share. | 05 Mar 2024 | 3,500 | 5,343,777 | - | 12.5 | 43,715 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.03 per share. | 04 Mar 2024 | 4,100 | 5,340,277 | - | 13.0 | 53,423 | Common Stock |
| Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.16 per share. | 16 Feb 2024 | 10,800 | 5,336,177 | - | 11.2 | 120,528 | Common Stock |
| S. Patel Snehal | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.07 per share. | 15 Feb 2024 | 12,700 | 5,325,377 | - | 11.1 | 140,589 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.97 per share. | 22 Aug 2023 | 1,000 | 5,291,177 | - | 10.0 | 9,970 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.55 per share. | 04 Aug 2023 | 2,000 | 5,290,177 | - | 10.6 | 21,100 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.20 per share. | 21 Jul 2023 | 1,000 | 5,288,177 | - | 9.2 | 9,200 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 9.49 per share. | 13 Jul 2023 | 250 | 259,248 | - | 9.5 | 2,373 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.69 per share. | 17 May 2023 | 1,000 | 5,287,177 | - | 11.7 | 11,690 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 11.22 per share. | 28 Apr 2023 | 250 | 258,998 | - | 11.2 | 2,805 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.10 per share. | 19 Apr 2023 | 7,000 | 5,286,177 | - | 11.1 | 77,700 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.12 per share. | 18 Apr 2023 | 2,000 | 5,279,177 | - | 11.1 | 22,240 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 11.87 per share. | 11 Apr 2023 | 1,000 | 258,745 | - | 11.9 | 11,870 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.42 per share. | 11 Apr 2023 | 5,000 | 5,271,177 | - | 12.4 | 62,100 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 12.71 per share. | 15 Mar 2023 | 250 | 257,745 | - | 12.7 | 3,178 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.12 per share. | 10 Mar 2023 | 1,000 | 2,737,486 | - | 12.1 | 12,120 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 15.40 per share. | 24 Feb 2023 | 250 | 257,495 | - | 15.4 | 3,849 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.53 per share. | 17 Feb 2023 | 600 | 2,736,486 | - | 16.5 | 9,918 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.68 per share. | 10 Feb 2023 | 1,000 | 2,735,886 | - | 18.7 | 18,680 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 20.84 per share. | 03 Feb 2023 | 250 | 257,245 | - | 20.8 | 5,210 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 19.20 per share. | 27 Jan 2023 | 250 | 256,995 | - | 19.2 | 4,800 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.35 per share. | 27 Jan 2023 | 2,000 | 2,734,886 | - | 19.4 | 38,700 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.37 per share. | 20 Jan 2023 | 1,500 | 2,732,886 | - | 17.4 | 26,055 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.50 per share. | 13 Jan 2023 | 250 | 256,745 | - | 16.5 | 4,125 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.18 per share. | 06 Jan 2023 | 1,500 | 2,731,386 | - | 15.2 | 22,770 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.19 per share. | 29 Dec 2022 | 4,000 | 2,729,886 | - | 15.2 | 60,760 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 12.94 per share. | 16 Dec 2022 | 250 | 256,495 | - | 12.9 | 3,235 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.01 per share. | 16 Dec 2022 | 1,000 | 2,725,886 | - | 13.0 | 13,010 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.11 per share. | 09 Dec 2022 | 2,000 | 2,724,886 | - | 13.1 | 26,220 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 13.98 per share. | 02 Dec 2022 | 250 | 256,245 | - | 14.0 | 3,495 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.84 per share. | 02 Dec 2022 | 1,000 | 2,722,886 | - | 13.8 | 13,840 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.79 per share. | 02 Nov 2022 | 2,000 | 2,721,886 | - | 8.8 | 17,580 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.75 per share. | 14 Oct 2022 | 3,000 | 2,719,886 | - | 9.8 | 29,250 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.72 per share. | 07 Oct 2022 | 2,000 | 2,716,886 | - | 9.7 | 19,440 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.46 per share. | 30 Sep 2022 | 1,000 | 2,714,886 | - | 9.5 | 9,460 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.23 per share. | 29 Sep 2022 | 1,000 | 2,713,886 | - | 9.2 | 9,230 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.13 per share. | 24 Jun 2022 | 6,465 | 2,712,886 | - | 9.1 | 59,025 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.13 per share. | 24 Jun 2022 | 22,535 | 2,706,421 | - | 9.1 | 205,745 | Common Stock |
| David B. McWilliams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 61,984 | 61,984 | - | - | Stock Options | |
| Jaye Thompson | VP Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 149,818 | 149,818 | - | - | Stock Options | |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,008 | 1,073,731 | - | - | Stock Options | |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 1,048,723 | 1,048,723 | - | - | Stock Options | |
| Eric Rothe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,349 | 41,349 | - | - | Stock Options | |
| Kenneth Hallock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,349 | 41,349 | - | - | Stock Options | |
| Frank Joseph Daugherty | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,890 | 104,890 | - | - | Stock Options | |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.13 per share. | 16 Jun 2022 | 8,000 | 2,683,886 | - | 7.1 | 57,040 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.91 per share. | 14 Jun 2022 | 12,000 | 2,675,886 | - | 7.9 | 94,920 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.33 per share. | 10 Jun 2022 | 12,000 | 2,663,886 | - | 8.3 | 99,960 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.90 per share. | 09 Jun 2022 | 4,500 | 1,243,453 | - | 10.9 | 49,050 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.55 per share. | 07 Jun 2022 | 6,000 | 1,238,953 | - | 8.6 | 51,300 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.35 per share. | 03 Jun 2022 | 9,250 | 1,232,953 | - | 8.4 | 77,238 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.38 per share. | 02 Jun 2022 | 6,774 | 1,223,703 | - | 7.4 | 49,992 | Common Stock |
| Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 16.25 per share. | 25 Apr 2022 | 1,000 | 90,121 | - | 16.3 | 16,250 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.09 per share. | 21 Apr 2022 | 6,000 | 1,216,929 | - | 16.1 | 96,540 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.74 per share. | 19 Apr 2022 | 500 | 255,995 | - | 16.7 | 8,370 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.74 per share. | 19 Apr 2022 | 6,000 | 1,210,929 | - | 16.7 | 100,440 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.80 per share. | 11 Feb 2022 | 5,500 | 1,204,929 | - | 19.8 | 108,900 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.59 per share. | 04 Feb 2022 | 5,000 | 1,199,429 | - | 19.6 | 97,950 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 18.47 per share. | 31 Jan 2022 | 500 | 255,495 | - | 18.5 | 9,235 | Common Stock |
| Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.33 per share. | 21 Jan 2022 | 500 | 254,995 | - | 16.3 | 8,165 | Common Stock |
| Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 16.32 per share. | 21 Jan 2022 | 300 | 397,304 | - | 16.3 | 4,896 | Common Stock |
| Jaye Thompson | VP Clinical Reg. Affairs | Purchase of securities on an exchange or from another person at price $ 18.87 per share. | 18 Jan 2022 | 500 | 254,495 | - | 18.9 | 9,435 | Common Stock |
| Jaye Thompson | VP Clinical Reg. Affairs | Purchase of securities on an exchange or from another person at price $ 19.99 per share. | 13 Jan 2022 | 1,000 | 253,995 | - | 20.0 | 19,990 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.99 per share. | 13 Jan 2022 | 1,000 | 1,194,429 | - | 20.0 | 19,990 | Common Stock |
| Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 19.99 per share. | 13 Jan 2022 | 1,000 | 89,121 | - | 20.0 | 19,990 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 23.82 per share. | 03 Jan 2022 | 2,050 | 1,193,429 | - | 23.8 | 48,831 | Common Stock |
| David B. McWilliams | Director | Purchase of securities on an exchange or from another person at price $ 27.56 per share. | 14 Dec 2021 | 200 | 620,301 | - | 27.6 | 5,512 | Common Stock |
| Snehal Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 27.17 per share. | 14 Dec 2021 | 1,840 | 1,191,379 | - | 27.2 | 49,992 | Common Stock |
| Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 26.99 per share. | 14 Dec 2021 | 1,111 | 88,121 | - | 27.0 | 29,983 | Common Stock |
| Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 36.98 per share. | 13 Apr 2021 | 2,700 | 1,189,539 | - | 37.0 | 99,853 | Common Stock |
| Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 5.39 per share. | 24 Nov 2020 | 1,000 | 397,004 | - | 5.4 | 5,386 | Common Stock |
| Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 23 Nov 2020 | 1,000 | 87,010 | - | 5.1 | 5,100 | Common Stock |
| David B. McWilliams | Director | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 20 Nov 2020 | 1,500 | 620,101 | - | 5.4 | 8,100 | Common Stock |
| Eric Rothe | Director | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 20 Nov 2020 | 2,000 | 313,226 | - | 5.4 | 10,800 | Common Stock |
| Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 5.37 per share. | 20 Nov 2020 | 1,000 | 396,004 | - | 5.4 | 5,370 | Common Stock |
| Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 19 Nov 2020 | 2,000 | 1,186,839 | - | 5.4 | 10,795 | Common Stock |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 152,604 | 599,583 | - | - | Common Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 1,054 | 0 | - | - | Series D Preferred Stock | |
| David B. McWilliams | Director | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 1,054 | 1,054 | - | - | Series D Preferred Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 6,555 | 0 | - | - | Series D Preferred Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 3,746 | 0 | - | - | Series C Preferred Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,663 | 0 | - | - | Series B Preferred Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 152,604 | 0 | - | - | Series A Preferred Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,609 | 618,601 | - | - | Common Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 3,746 | 610,992 | - | - | Common Stock | |
| David B. McWilliams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,663 | 607,246 | - | - | Common Stock | |
| David B. McWilliams | Director | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 2,608 | 446,979 | - | 5.8 | 14,996 | Common Stock |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 45,328 | 0 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 114,347 | 863,683 | - | 5.7 | 657,495 | Common Stock |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 176,448 | 1,040,131 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 13,736 | 1,053,867 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 10,394 | 1,064,261 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 103,911 | 1,168,172 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 1,144,529 | 1,321,327 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 2,997 | 1,324,324 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 33,708 | 1,358,032 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 50,001 | 1,408,033 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 76,780 | 76,780 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 52,620 | 129,400 | - | - | Common Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 176,448 | 0 | - | - | Series A Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 1,144,529 | 0 | - | - | Series A Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 13,736 | 0 | - | - | Series B Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 76,780 | 0 | - | - | Series B Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 2,997 | 0 | - | - | Series B Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 10,394 | 0 | - | - | Series C Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 33,708 | 0 | - | - | Series C Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 89,510 | 0 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 43,072 | 0 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 14,401 | 14,401 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 6,929 | 6,929 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 7,292 | 7,292 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 14,401 | 0 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 6,929 | 0 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 7,292 | 0 | - | - | Series D Preferred Stock | |
| Snehal Patel | Director, CEO and CFO | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 29 Sep 2020 | 16,667 | 1,184,839 | - | 4.6 | 76,710 | Common Stock |
| Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 276,095 | - | - | Common Stock | |
| Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 79,121 | 386,671 | - | - | Common Stock | |
| Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 0 | - | - | Series B Preferred Stock | |
| Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 0 | - | - | Series C Preferred Stock | |
| Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 12,728 | 0 | - | - | Series D Preferred Stock | |
| Kenneth Hallock | Director | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 12,728 | 12,728 | - | - | Series D Preferred Stock | |
| Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 79,121 | 0 | - | - | Series D Preferred Stock | |
| Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 74,782 | 257,368 | - | 5.8 | 429,997 | Common Stock |
| Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 294,822 | - | - | Common Stock | |
| Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 29 Sep 2020 | 8,333 | 395,004 | - | 4.6 | 38,353 | Common Stock |
| Frank Joseph Daugherty | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 1,739 | 86,010 | - | 5.7 | 9,999 | Common Stock |